• Product NameLatanoprost
• Brief DescriptionInhibitors
• Purification99.69%
• Biological ActivityLatanoprost is a prostaglandin F2a analogue used for controlling the progression of glaucoma or ocular hypertension.
• Target NameGPR agonist; RAR/RXR? antagonist
• CAS No. 130209-82-4
• Calculated MW 432.59
• Formulation C26H40O5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Endocrine system
  SMILES:CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O
  Pathways:Endocrinology/Hormones; Metabolism
  Receptor:prostanoid selective FP receptor; retinoid X receptor α
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:Liquid
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Patel SS and CM Spencer Latanoprost. Drugs Aging, 1996. 9(5): p. 363-78.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting